These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 22042322)
1. Epilepsy in Sweden: health care costs and loss of productivity--a register-based approach. Bolin K; Lundgren A; Berggren F; Källén K Eur J Health Econ; 2012 Dec; 13(6):819-26. PubMed ID: 22042322 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and cost of epilepsy in Sweden--a register-based approach. Bolin K; Berggren F; Landtblom AM Acta Neurol Scand; 2015 Jan; 131(1):37-44. PubMed ID: 25195857 [TBL] [Abstract][Full Text] [Related]
3. Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts. Jönsen A; Hjalte F; Willim M; Carlsson KS; Sjöwall C; Svenungsson E; Leonard D; Bengtsson C; Rantapää-Dahlqvist S; Pettersson S; Gunnarsson I; Zickert A; Gustafsson JT; Rönnblom L; Petersson IF; Bengtsson AA; Nived O Semin Arthritis Rheum; 2016 Jun; 45(6):684-90. PubMed ID: 26743074 [TBL] [Abstract][Full Text] [Related]
4. The economic burden of prostate cancer - a Swedish prevalence-based register study. Hao S; Östensson E; Eklund M; Grönberg H; Nordström T; Heintz E; Clements M BMC Health Serv Res; 2020 May; 20(1):448. PubMed ID: 32434566 [TBL] [Abstract][Full Text] [Related]
5. The societal cost of schizophrenia in Sweden. Ekman M; Granstrom O; Omerov S; Jacob J; Landen M J Ment Health Policy Econ; 2013 Mar; 16(1):13-25. PubMed ID: 23676412 [TBL] [Abstract][Full Text] [Related]
6. Cost of disorders of the brain in Europe 2010. Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J; Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer, healthcare cost, and loss of productivity: a register-based approach. Tingstedt B; Andersson E; Flink A; Bolin K; Lindgren B; Andersson R World J Surg; 2011 Oct; 35(10):2298-305. PubMed ID: 21850604 [TBL] [Abstract][Full Text] [Related]
8. Non-adherence to drug therapy and drug acquisition costs in a national population--a patient-based register study. Hovstadius B; Petersson G BMC Health Serv Res; 2011 Nov; 11():326. PubMed ID: 22123025 [TBL] [Abstract][Full Text] [Related]
9. Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden. Banefelt J; Hallberg S; Fox KM; Mesterton J; Paoli CJ; Johansson G; Levin LÅ; Sobocki P; Gandra SR Eur J Health Econ; 2016 Dec; 17(9):1117-1124. PubMed ID: 26607457 [TBL] [Abstract][Full Text] [Related]
10. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005--a register-based approach. Bolin K; Gip C; Mörk AC; Lindgren B Diabet Med; 2009 Sep; 26(9):928-34. PubMed ID: 19719715 [TBL] [Abstract][Full Text] [Related]
11. Economic burden of schizophrenia: empirical analyses from a survey in Thailand. Phanthunane P; Whiteford H; Vos T; Bertram M J Ment Health Policy Econ; 2012 Mar; 15(1):25-32. PubMed ID: 22611090 [TBL] [Abstract][Full Text] [Related]
12. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China. Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782 [TBL] [Abstract][Full Text] [Related]
13. Economic burden of epilepsy in India. Thomas SV; Sarma PS; Alexander M; Pandit L; Shekhar L; Trivedi C; Vengamma B Epilepsia; 2001 Aug; 42(8):1052-60. PubMed ID: 11554893 [TBL] [Abstract][Full Text] [Related]
14. Cost of illness of cystic fibrosis in Germany: results from a large cystic fibrosis centre. Heimeshoff M; Hollmeyer H; Schreyögg J; Tiemann O; Staab D Pharmacoeconomics; 2012 Sep; 30(9):763-77. PubMed ID: 22690685 [TBL] [Abstract][Full Text] [Related]
15. Economic burden of epilepsy among the privately insured in the US. Ivanova JI; Birnbaum HG; Kidolezi Y; Qiu Y; Mallett D; Caleo S Pharmacoeconomics; 2010; 28(8):675-85. PubMed ID: 20623993 [TBL] [Abstract][Full Text] [Related]
16. Side-effects of antiepileptic drugs: the economic burden. de Kinderen RJ; Evers SM; Rinkens R; Postulart D; Vader CI; Majoie MH; Aldenkamp AP Seizure; 2014 Mar; 23(3):184-90. PubMed ID: 24315662 [TBL] [Abstract][Full Text] [Related]
17. A comparison of two methods for estimating the health care costs of epilepsy. Frost FJ; Hurley JS; Petersen HV; Gunter MJ; Gause D Epilepsia; 2000 Aug; 41(8):1020-6. PubMed ID: 10961630 [TBL] [Abstract][Full Text] [Related]
18. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Begley CE; Famulari M; Annegers JF; Lairson DR; Reynolds TF; Coan S; Dubinsky S; Newmark ME; Leibson C; So EL; Rocca WA Epilepsia; 2000 Mar; 41(3):342-51. PubMed ID: 10714408 [TBL] [Abstract][Full Text] [Related]
19. The economic burden of human papillomavirus-related precancers and cancers in Sweden. Östensson E; Silfverschiöld M; Greiff L; Asciutto C; Wennerberg J; Lydrup ML; Håkansson U; Sparén P; Borgfeldt C PLoS One; 2017; 12(6):e0179520. PubMed ID: 28651012 [TBL] [Abstract][Full Text] [Related]
20. Smoking, healthcare cost, and loss of productivity in Sweden 2001. Bolin K; Lindgren B Scand J Public Health; 2007; 35(2):187-96. PubMed ID: 17454923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]